Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 121

1.

High C-X-C motif chemokine 5 expression is associated with malignant phenotypes of prostate cancer cells via autocrine and paracrine pathways.

Qi Y, Zhao W, Li M, Shao M, Wang J, Sui H, Yu H, Shao W, Gui S, Li J, Jia X, Jiang D, Li Y, Zhang P, Wang S, Wang W.

Int J Oncol. 2018 Jul;53(1):358-370. doi: 10.3892/ijo.2018.4388. Epub 2018 Apr 30.

PMID:
29749439
2.

CXCL5 promotes mitomycin C resistance in non-muscle invasive bladder cancer by activating EMT and NF-κB pathway.

Wang C, Li A, Yang S, Qiao R, Zhu X, Zhang J.

Biochem Biophys Res Commun. 2018 Apr 15;498(4):862-868. doi: 10.1016/j.bbrc.2018.03.071. Epub 2018 Mar 17.

PMID:
29545183
3.

CXCL5 regulation of proliferation and migration in human non-small cell lung cancer cells.

Wang L, Shi L, Gu J, Zhan C, Xi J, Ding J, Ge D.

J Physiol Biochem. 2018 May;74(2):313-324. doi: 10.1007/s13105-018-0619-z. Epub 2018 Mar 10.

PMID:
29526026
4.

Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway.

Cui D, Zhao Y, Xu J.

Biochimie. 2018 May;148:1-11. doi: 10.1016/j.biochi.2018.02.009. Epub 2018 Feb 20.

PMID:
29471001
5.

Reduced ENA78 levels as novel biomarker for major depressive disorder and venlafaxine efficiency: Result from a prospective longitudinal study.

Li Z, Wang Z, Zhang C, Chen J, Su Y, Huang J, Yi Z, Yuan C, Hong W, Wang Y, Wu Z, Hu Y, Cao L, Peng D, Guan Y, Zou Y, Yu S, Cui D, Fang Y.

Psychoneuroendocrinology. 2017 Jul;81:113-121. doi: 10.1016/j.psyneuen.2017.03.015. Epub 2017 Mar 18.

PMID:
28441588
6.

Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways.

Zhao J, Ou B, Han D, Wang P, Zong Y, Zhu C, Liu D, Zheng M, Sun J, Feng H, Lu A.

Mol Cancer. 2017 Mar 29;16(1):70. doi: 10.1186/s12943-017-0629-4.

7.

CXCL5 Plays a Promoting Role in Osteosarcoma Cell Migration and Invasion in Autocrine- and Paracrine-Dependent Manners.

Dang H, Wu W, Wang B, Cui C, Niu J, Chen J, Chen Z, Liu Y.

Oncol Res. 2017 Jan 26;25(2):177-186. doi: 10.3727/096504016X14732772150343.

PMID:
28277189
8.

Neutrophil infiltration mediated by CXCL5 accumulation in the laryngeal squamous cell carcinoma microenvironment: A mechanism by which tumour cells escape immune surveillance.

Zhang D, Zhou J, Tang D, Zhou L, Chou L, Chou KY, Tao L, Lu LM.

Clin Immunol. 2017 Feb;175:34-40. doi: 10.1016/j.clim.2016.11.009. Epub 2016 Nov 19.

PMID:
27876461
9.

CXCL5 promotes the proliferation and migration of glioma cells in autocrine- and paracrine-dependent manners.

Dai Z, Wu J, Chen F, Cheng Q, Zhang M, Wang Y, Guo Y, Song T.

Oncol Rep. 2016 Dec;36(6):3303-3310. doi: 10.3892/or.2016.5155. Epub 2016 Oct 10.

PMID:
27748886
10.

Molecular Basis of Chemokine CXCL5-Glycosaminoglycan Interactions.

Sepuru KM, Nagarajan B, Desai UR, Rajarathnam K.

J Biol Chem. 2016 Sep 23;291(39):20539-50. doi: 10.1074/jbc.M116.745265. Epub 2016 Jul 28.

11.

Increased plasma levels of epithelial neutrophil-activating peptide 78/CXCL5 during the remission of Neuromyelitis optica.

Yang T, Wang S, Zheng Q, Wang L, Li Q, Wei M, Du Z, Fan Y.

BMC Neurol. 2016 Jul 11;16:96. doi: 10.1186/s12883-016-0622-3.

12.

CXCL5 is a potential diagnostic and prognostic marker for bladder cancer patients.

Zhu X, Qiao Y, Liu W, Wang W, Shen H, Lu Y, Hao G, Zheng J, Tian Y.

Tumour Biol. 2016 Apr;37(4):4569-77. doi: 10.1007/s13277-015-4275-4. Epub 2015 Oct 27.

PMID:
26503215
13.
14.

UV radiation induces CXCL5 expression in human skin.

Reichert O, Kolbe L, Terstegen L, Staeb F, Wenck H, Schmelz M, Genth H, Kaever V, Roggenkamp D, Neufang G.

Exp Dermatol. 2015 Apr;24(4):309-12. doi: 10.1111/exd.12652.

PMID:
25690483
15.

Transcriptional Regulation of CXCL5 in HIV-1-Infected Macrophages and Its Functional Consequences on CNS Pathology.

Guha D, Klamar CR, Reinhart T, Ayyavoo V.

J Interferon Cytokine Res. 2015 May;35(5):373-84. doi: 10.1089/jir.2014.0135. Epub 2014 Dec 23.

16.

Roles of CXCL5 on migration and invasion of liver cancer cells.

Xu X, Huang P, Yang B, Wang X, Xia J.

J Transl Med. 2014 Jul 10;12:193. doi: 10.1186/1479-5876-12-193.

17.

Citrullination of epithelial neutrophil-activating peptide 78/CXCL5 results in conversion from a non-monocyte-recruiting chemokine to a monocyte-recruiting chemokine.

Yoshida K, Korchynskyi O, Tak PP, Isozaki T, Ruth JH, Campbell PL, Baeten DL, Gerlag DM, Amin MA, Koch AE.

Arthritis Rheumatol. 2014 Oct;66(10):2716-27. doi: 10.1002/art.38750.

18.

Solution structure of CXCL5--a novel chemokine and adipokine implicated in inflammation and obesity.

Sepuru KM, Poluri KM, Rajarathnam K.

PLoS One. 2014 Apr 2;9(4):e93228. doi: 10.1371/journal.pone.0093228. eCollection 2014.

19.

CXCL5 knockdown expression inhibits human bladder cancer T24 cells proliferation and migration.

Zheng J, Zhu X, Zhang J.

Biochem Biophys Res Commun. 2014 Mar 28;446(1):18-24. doi: 10.1016/j.bbrc.2014.01.172. Epub 2014 Feb 26.

PMID:
24583128
20.

CXCL5 as a potential novel prognostic factor in early stage non-small cell lung cancer: results of a study of expression levels of 23 genes.

Kowalczuk O, Burzykowski T, Niklinska WE, Kozlowski M, Chyczewski L, Niklinski J.

Tumour Biol. 2014 May;35(5):4619-28. doi: 10.1007/s13277-014-1605-x. Epub 2014 Feb 6.

Supplemental Content

Support Center